Pfizer, BioNTech Seek Emergency Use Authorization For COVID-19 Vaccine
Another vaccine from Moderna Inc. is showing similar results and the U.S. has agreed to buy millions of the Pfizer-BioNTech doses upon approval.
Drugmaker Pfizer and its German partner BioNTech submitted an application for emergency use authorization for a COVID-19 vaccine.
The companies say data shows the vaccine is 95% effective at preventing the disease. A second vaccine, from Moderna Inc., is showing similar results.
The U.S. has a contract to buy millions of the Pfizer-BioNTech doses once that vaccine is approved, with shots to be free of charge.
How you can clean the air to protect yourself from COVID
People can remove harmful aerosol particles, like the virus that causes COVID, from the air on their own terms.
Moderna defends vax price hike, despite billions in taxpayer funding
The company is planning to raise the price of its COVID-19 vaccine from about $26 per dose up to $130 per dose.
What living with long COVID is really like
Scripps News talked to a dozen people with long-term COVID symptoms about their current experience and their hope for the future.
Sam Bankman-Fried charged with paying $40M bribe to China
The embattled FTX founder is accused of paying "one or more" Chinese officials to unfreeze assets linked to his hedge fund, Alameda Research.
Behind the scenes, a handful of women play key roles in US Capitol
It's women in the U.S. Capitol who are filling the top roles essential to keep the institution humming.
Adnan Syed's murder conviction reinstated, for now
A Baltimore court reinstated the conviction of Adnan Syed as a procedural matter, but said it wishes not to violate his "right to be free."